Liberatii ^Company

Evaxion announced that the company will present clinical readout of the Phase 1/2a trial of EVX-02 at the upcoming 2023 American Association for Cancer Research Annual Meeting (2023 AACR), taking place from April 14th to April 19th in Orlando, Florida. ... As pioneers and leaders in AI-powered immunotherapy, we seek, employ and develop the best ...